Hironobu Hamada

15PUBLICATIONS
33CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Gender relations
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 06, 2026
Correction: Clinical implications of serum total VEGF-A and VEGF-A isoforms in patients with EGFR-mutated advanced non-small cell lung cancer treated with EGFR-TKIs.

|Jun 09, 2026
Clinical implications of serum total VEGF-A and VEGF-A isoforms in patients with EGFR-mutated advanced non-small cell lung cancer treated with EGFR-TKIs.

|Mar 30, 2026
Tumor-Bearing Status Accelerates Bleomycin-Induced Pulmonary Inflammation via Endothelial Activation.

Shoko Isoyama, Kakuhiro Yamaguchi, Hiroshi Iwamoto

|Dec 05, 2025
Two Cases of Epidermal Growth Factor Receptor L861R Mutation-Positive Lung Adenocarcinoma Treated With Osimertinib and Afatinib.

Kei Kagawa, Takeshi Masuda, Kiyofumi Shimoji

|Nov 06, 2025
Plasminogen Activator Inhibitor-1 Mediates Tolerance to Anti-PD-1 Immunotherapy in Non-Small Cell Lung Cancer.

Masahiko Sumii, Takeshi Masuda, Kiyofumi Shimoji

|Feb 26, 2025
Predictive Value of Circulatory Total VEGF-A and VEGF-A Isoforms for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small-Cell Lung Cancer.

Tetsu Hirakawa, Kakuhiro Yamaguchi, Kunihiko Funaishi

Pageof 3

Frequent Collaborators

9 joint publications

Kakuhiro Yamaguchi

8 joint publications

Hiroshi Iwamoto

7 joint publications

Takeshi Masuda

7 joint publications

Taku Nakashima